drugset / Trial / NCT01833767
Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine response rates by administering low dose cyclophosphamide on day 1, followed by 5 days of outpatient IL2.
Timeline
- Start
- 2012-10
- Primary completion
- 2015-12
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped (Enrollment): “No participants enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Subject | aldesleukin | Protein / enzyme biologic | — | Intravenous |